Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.94 USD | +1.85% | +8.29% | -5.18% |
May. 10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
May. 09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Biopharmaceuticals | +1.85% | +8.29% | -5.18% | +12.65% | +407.64% | 1.88B |
- Stock Market
- Equities
- CPRX Stock
- Charts Catalyst Pharmaceuticals, Inc.
- Relative Strength Chart